This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Mar 13, 2026
Tevogen Bio reveals major performance updates to its PredicTcell AI platform, achieving a 92% recall rate and expanding its proprietary database to 655 million peptide sequences to accelerate immunothera
Sep 15, 2026
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

